CA1195621A - Blood reservoir - Google Patents
Blood reservoirInfo
- Publication number
- CA1195621A CA1195621A CA000434169A CA434169A CA1195621A CA 1195621 A CA1195621 A CA 1195621A CA 000434169 A CA000434169 A CA 000434169A CA 434169 A CA434169 A CA 434169A CA 1195621 A CA1195621 A CA 1195621A
- Authority
- CA
- Canada
- Prior art keywords
- blood
- midsection
- reservoir
- leg
- yoke
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/165—Filtering accessories, e.g. blood filters, filters for infusion liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/36—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests with means for eliminating or preventing injection or infusion of air into body
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/03—Heart-lung
Abstract
S P E C I F I C A T I O N
BLOOD RESERVOIR
ABSTRACT
A yoke shaped collapsible blood reservoir having first and second yoke legs joined by a yoke midsection. A
filter element is positioned in the yoke midsection and across the blood flow path between an inlet at the base of the first yoke leg and a blood outlet at the base of the second yoke leg. An angular blood inlet and a gradual increase in cross-sectional area from the blood inlet to the yoke midsection decreases turbulence and assists in bubble separation.
BLOOD RESERVOIR
ABSTRACT
A yoke shaped collapsible blood reservoir having first and second yoke legs joined by a yoke midsection. A
filter element is positioned in the yoke midsection and across the blood flow path between an inlet at the base of the first yoke leg and a blood outlet at the base of the second yoke leg. An angular blood inlet and a gradual increase in cross-sectional area from the blood inlet to the yoke midsection decreases turbulence and assists in bubble separation.
Description
~" 13L95~
BACKGROUND OF THE INVENTION
Field of the Invention The pres~nt invention relate-s to-a-collapsible blood reservoir for use in a cardiopulmonary bypass system.
~escription of the Prior Art Generally, a cardiopulmonary bypass system is a medical system used in cardiovascular surgery, intensive care and surgical recovery that is coupled to a human body to revitalize and pump blood, thereby performing certain functions of the h~art and lungs and often partially or fully bypassing a portion of the circulatory system. The cardiopulmanary bypass system receives a venous blood feed (oxygen deicient blood) from the human circulatory system, oxygenates and typically transfers heat with the blood and returns the blood to the circulatory system at a 10w rate approximately corresponding to the venous drainage, thus reducing the load on the lungs and hear~.
A cardiopulmonary bypass system in a partial sup-port capacity is used, for example, during cardiac inten~ive care of patients who have suffered a cardiac infarction where a portion of the heart muscle has died rom an insuf-ficient blood supply. The dead muscle is soft and difficult -~ S~Z~
to suture since it will tear easilyO The muscle may heal if the patient is kept quiet and heart chambers are subject to a minimum amount of pressure. Failing such --- care, an aneurysm may result in which the sotened muscle S swells up and stagnates pools of ~lood which tend ~o clot~
The tendency toward development o~ an aneurysm is minimized reducing the pumping load on the hear t with the partial support system. Typically the infarcted tissue scars over and thereby regains its tensile integrity in several weeks during which time the cardiopulmonary bypass system must operate continously. Recent developmen~s in pump oxygena~ion equipment, such as membrane oxygenators having limited long term blood degradation effects, have made possible long term partial support of this duration.
Many specific requirements must be met in a practical partial su~port system. For example, the cardiopulmonary bypass system experiences a~load as the~
blood is returned to the human body. The load is variable and the ~low imp~dance seen by the cardiopul~onary bypass system may increase if, for example, the arteries are constricting or decrease when hemorrhaglng is occurring.
Yet the cardiopulmonary bypass system should generall~y maintain a constant flow rate to the human body, equal to the venous drainage.
The rate and changes in rate of blood flow indicates the physical state of the patient, and thus it would be desirable to~ monitor the blood flow rate~ The ~956~:~
physician may find it necessary to~increase or decrease the return flow rate of the blood. Increasing the blood flow rate in excess of the drainage rate often requ-ires the addition of blood to the system. It would be advanta geous to have a cardiopulmonary bypass system which could introduce quantities of blood to the blood flow in addition to ~he blood supplied by the patient's circulatory system.
The quantity of blood flowing in the circulatory 10 system of a young infant is extremely critical. For -example, hyaline membrane disease attacks the alveolar sacks of infants. When this occurs, the lining of the lungs is impervious to oxygen and CO2 Since the infant having this disease receives insufficient oxygen, the treatment in the past has been to increase, in concentra-tion and pressure, the oxygen provided to the infant.
Although ~he disease is often cured by this technique, o~her serious conditions may set in which are caused by ~he toxic effects o~ oxygen such as retrolental fibro-plasia, in which the retina is destroyed. By using a cardiopulmonary bypass system, the lungs are allowed to heal. The control of blood volume is extremely important since the hyaline disease typically occurs with underweight infants, ~ypically less than 2500 grams and having a total blood volume of only 150-300cco Thus, it would be desirable to have a cardiopulmo-nary bypass system that is safe, reliable and volume alterable.
~L~L95~
The present invention provides a blood reservoi.r com prising: a substantially inverted U shaped reservoir chamber having first and second U legs joined by a U midsection; a sub-stan-tially cylindrical inlet at the base of said first U leg said inlet aligned such that its centerline projects upwardly from the centerline of said first U leg; an outlet at the base of said second U leg; and a vent at the uppermost portion of the U mid-section.
The invention also provides a flexible collapsible LO blood reservoir comprising: a substantially U shaped reservoir chamber having first and second U legs joined by a U midsection wherein the ratio of the height of the reservoir chamber to the height of the center of the U midsection is between about 1.7 and 1.2; a blood inlet at the base of said first U leg; a blood outlet at the base of said second U leg; a non-flexible filter e:Lement positi.oned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost port.ion of the U midsection.
The invention Eurther provides a flexible collapsible ~0 b.~oo~ reservoir comprising: a .substantially U shaped reservoir chamber having first and second U legs joined by a U midsection, the cross-sectional area of said U being greatest at the U mid-section and gradually decreasing toward each U leg base; a fil.ter element positioned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost portion o:E the U midsection.
: In the accompanying drawings:
Figure 1 is a cross--sectional view of the present ; invention.
Figure 2 is a cross-sectional view taken about 2-2 of Figure 1.
~ 5 ~
~. ~9S6~
Referring to Figure 1, in a preferred embodiment blood reservoir 1 includes a yoke shaped reservoir chamber .. ~
~ 5a -356i~
3 and a support member 23 having apertures 21 therein suitable for hanging the device from a stand. Yoke shaped reservoir chamber 3 includes a first yoke leg 5 and a second yoke leg 7 joined by, and in fluid communication with, a yoke midsection g. The yoke shaped reservoir chamber is preferably collapsible and flexible such that the chamber will collapse as fluid is withdrawn thereby preventing gas bubbles from passing out through outlet 13.
Blood inlet 11 is provided in the first yoke leg 5 and blood outlet 13 is positioned in the second yoke leg 7. In a preferred embodiment ~he centerline of the blood inlet 11 and blood outlet 13 are positioned a~ an upward angle with respect to the centerline of the yoke leg 5, 7 lS centerlines, respectively, such that the angle between the centerline o~ the blood inlet 11 and blood outle~ 13 and horizontal is between about 30 and about 60.
Further, the cross-sectional area of the reservoir chamber 3 is such that it increases gradually from tapered blood inlet 11 toward the yoke midsection 9 and then gradually decreases toward tapered blood outlet 13. Such an angular blood inlet 11 and ~radual cross-sectional area increase towa~-d the yoke midsection 9 decrease turbulence . within the blood reservoir 1 and assists in bubble separation.
2S A vent 19 is provided at the approximate up~ermost portion of yoke midsection 9 to allow for the venting of such separated gases. The ratio of the heiyht of the reservoir , ~:~l95~
chamber 3 (hl) to the height of the center of the yoke midesection 9 (h2) is preferably between about 1.7 --- -and about 1.2. In a further preferred embodiment the ra~io of the height to ~he width of the reservoir chamber 5 3 i5 less than 1.0 so that a relatively large volume of fluid can be reservoired by the reservoir chamber 3 without a correspondingly large hydraulic head.
A filter means lS is provided within the yoke midsection 9 and across blood flow path 17. Filter means 15 is preferably one having a pore size of between about 100 and 250 microns~ The blood reservoir 1 is preferably formed ~rom flexible thin walled polyvinylchloride, polyurethane or polyethylene plastic material such that the yoke shaped blood reservoir chamber 3 will expand and collapse as the rate of incoming blood increases and decreases, respectivelyO The yoke shaped blood reservoir 3 is sufficiently flexible such that when the operative use o the blood reservoir 1 is drawing to a close, first yoke leg 3 may be grasped and elevated so that it i5 above the yoke midseckion 9 thereby forcing the remaining reservoired blood to pass through filter means 15 and ou~
through blood outlet 13.
While the invention has been particularly shown and described, and with reference to certain preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and 0 details without depar`ting from the spirit and scope of the invention.
BACKGROUND OF THE INVENTION
Field of the Invention The pres~nt invention relate-s to-a-collapsible blood reservoir for use in a cardiopulmonary bypass system.
~escription of the Prior Art Generally, a cardiopulmonary bypass system is a medical system used in cardiovascular surgery, intensive care and surgical recovery that is coupled to a human body to revitalize and pump blood, thereby performing certain functions of the h~art and lungs and often partially or fully bypassing a portion of the circulatory system. The cardiopulmanary bypass system receives a venous blood feed (oxygen deicient blood) from the human circulatory system, oxygenates and typically transfers heat with the blood and returns the blood to the circulatory system at a 10w rate approximately corresponding to the venous drainage, thus reducing the load on the lungs and hear~.
A cardiopulmonary bypass system in a partial sup-port capacity is used, for example, during cardiac inten~ive care of patients who have suffered a cardiac infarction where a portion of the heart muscle has died rom an insuf-ficient blood supply. The dead muscle is soft and difficult -~ S~Z~
to suture since it will tear easilyO The muscle may heal if the patient is kept quiet and heart chambers are subject to a minimum amount of pressure. Failing such --- care, an aneurysm may result in which the sotened muscle S swells up and stagnates pools of ~lood which tend ~o clot~
The tendency toward development o~ an aneurysm is minimized reducing the pumping load on the hear t with the partial support system. Typically the infarcted tissue scars over and thereby regains its tensile integrity in several weeks during which time the cardiopulmonary bypass system must operate continously. Recent developmen~s in pump oxygena~ion equipment, such as membrane oxygenators having limited long term blood degradation effects, have made possible long term partial support of this duration.
Many specific requirements must be met in a practical partial su~port system. For example, the cardiopulmonary bypass system experiences a~load as the~
blood is returned to the human body. The load is variable and the ~low imp~dance seen by the cardiopul~onary bypass system may increase if, for example, the arteries are constricting or decrease when hemorrhaglng is occurring.
Yet the cardiopulmonary bypass system should generall~y maintain a constant flow rate to the human body, equal to the venous drainage.
The rate and changes in rate of blood flow indicates the physical state of the patient, and thus it would be desirable to~ monitor the blood flow rate~ The ~956~:~
physician may find it necessary to~increase or decrease the return flow rate of the blood. Increasing the blood flow rate in excess of the drainage rate often requ-ires the addition of blood to the system. It would be advanta geous to have a cardiopulmonary bypass system which could introduce quantities of blood to the blood flow in addition to ~he blood supplied by the patient's circulatory system.
The quantity of blood flowing in the circulatory 10 system of a young infant is extremely critical. For -example, hyaline membrane disease attacks the alveolar sacks of infants. When this occurs, the lining of the lungs is impervious to oxygen and CO2 Since the infant having this disease receives insufficient oxygen, the treatment in the past has been to increase, in concentra-tion and pressure, the oxygen provided to the infant.
Although ~he disease is often cured by this technique, o~her serious conditions may set in which are caused by ~he toxic effects o~ oxygen such as retrolental fibro-plasia, in which the retina is destroyed. By using a cardiopulmonary bypass system, the lungs are allowed to heal. The control of blood volume is extremely important since the hyaline disease typically occurs with underweight infants, ~ypically less than 2500 grams and having a total blood volume of only 150-300cco Thus, it would be desirable to have a cardiopulmo-nary bypass system that is safe, reliable and volume alterable.
~L~L95~
The present invention provides a blood reservoi.r com prising: a substantially inverted U shaped reservoir chamber having first and second U legs joined by a U midsection; a sub-stan-tially cylindrical inlet at the base of said first U leg said inlet aligned such that its centerline projects upwardly from the centerline of said first U leg; an outlet at the base of said second U leg; and a vent at the uppermost portion of the U mid-section.
The invention also provides a flexible collapsible LO blood reservoir comprising: a substantially U shaped reservoir chamber having first and second U legs joined by a U midsection wherein the ratio of the height of the reservoir chamber to the height of the center of the U midsection is between about 1.7 and 1.2; a blood inlet at the base of said first U leg; a blood outlet at the base of said second U leg; a non-flexible filter e:Lement positi.oned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost port.ion of the U midsection.
The invention Eurther provides a flexible collapsible ~0 b.~oo~ reservoir comprising: a .substantially U shaped reservoir chamber having first and second U legs joined by a U midsection, the cross-sectional area of said U being greatest at the U mid-section and gradually decreasing toward each U leg base; a fil.ter element positioned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost portion o:E the U midsection.
: In the accompanying drawings:
Figure 1 is a cross--sectional view of the present ; invention.
Figure 2 is a cross-sectional view taken about 2-2 of Figure 1.
~ 5 ~
~. ~9S6~
Referring to Figure 1, in a preferred embodiment blood reservoir 1 includes a yoke shaped reservoir chamber .. ~
~ 5a -356i~
3 and a support member 23 having apertures 21 therein suitable for hanging the device from a stand. Yoke shaped reservoir chamber 3 includes a first yoke leg 5 and a second yoke leg 7 joined by, and in fluid communication with, a yoke midsection g. The yoke shaped reservoir chamber is preferably collapsible and flexible such that the chamber will collapse as fluid is withdrawn thereby preventing gas bubbles from passing out through outlet 13.
Blood inlet 11 is provided in the first yoke leg 5 and blood outlet 13 is positioned in the second yoke leg 7. In a preferred embodiment ~he centerline of the blood inlet 11 and blood outlet 13 are positioned a~ an upward angle with respect to the centerline of the yoke leg 5, 7 lS centerlines, respectively, such that the angle between the centerline o~ the blood inlet 11 and blood outle~ 13 and horizontal is between about 30 and about 60.
Further, the cross-sectional area of the reservoir chamber 3 is such that it increases gradually from tapered blood inlet 11 toward the yoke midsection 9 and then gradually decreases toward tapered blood outlet 13. Such an angular blood inlet 11 and ~radual cross-sectional area increase towa~-d the yoke midsection 9 decrease turbulence . within the blood reservoir 1 and assists in bubble separation.
2S A vent 19 is provided at the approximate up~ermost portion of yoke midsection 9 to allow for the venting of such separated gases. The ratio of the heiyht of the reservoir , ~:~l95~
chamber 3 (hl) to the height of the center of the yoke midesection 9 (h2) is preferably between about 1.7 --- -and about 1.2. In a further preferred embodiment the ra~io of the height to ~he width of the reservoir chamber 5 3 i5 less than 1.0 so that a relatively large volume of fluid can be reservoired by the reservoir chamber 3 without a correspondingly large hydraulic head.
A filter means lS is provided within the yoke midsection 9 and across blood flow path 17. Filter means 15 is preferably one having a pore size of between about 100 and 250 microns~ The blood reservoir 1 is preferably formed ~rom flexible thin walled polyvinylchloride, polyurethane or polyethylene plastic material such that the yoke shaped blood reservoir chamber 3 will expand and collapse as the rate of incoming blood increases and decreases, respectivelyO The yoke shaped blood reservoir 3 is sufficiently flexible such that when the operative use o the blood reservoir 1 is drawing to a close, first yoke leg 3 may be grasped and elevated so that it i5 above the yoke midseckion 9 thereby forcing the remaining reservoired blood to pass through filter means 15 and ou~
through blood outlet 13.
While the invention has been particularly shown and described, and with reference to certain preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and 0 details without depar`ting from the spirit and scope of the invention.
Claims (10)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A blood reservoir comprising:
a substantailly inverted U shaped reservoir chamber having first and second U legs joined by a U midsection;
a substantially cylindrical inlet at the base of said first U leg said inlet aligned such that its centerline projects up-wardly from the centerline of said first U leg;
an outlet at the base of said second U leg; and a vent at the uppermost portion of the U midsection.
a substantailly inverted U shaped reservoir chamber having first and second U legs joined by a U midsection;
a substantially cylindrical inlet at the base of said first U leg said inlet aligned such that its centerline projects up-wardly from the centerline of said first U leg;
an outlet at the base of said second U leg; and a vent at the uppermost portion of the U midsection.
2. The blood reservoir claimed in claim 1 wherein said reservoir further includes a filter element at said U midsection and positioned across the blood flow path between said blood in-let and said blood outlet said filter element is more particularly defined as having a pore size of between about 100 microns to about 250 microns.
3. The blood reservoir in claim 1 wherein said substantially invented U shaped reservoir chamber is made from plastic.
4. The blood reservoir claimed in claim 1 wherein the ratio of the height of the reservoir chamber to the height of the center of the U midsection is between about 1.7 and about 1.2.
5. A flexible collapsible blood reservoir comprising:
a substantially U shaped reservoir chamber having first and second U legs joined by a U midsection wherein the ratio of the height of the reservoir chamber to the height of the center of the U midsection is between about 1.7 and about 1.2;
a blood inlet at the base of said first U leg;
a blood outlet at the base of said second U leg;
a non-flexible filter element positioned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost portion of the U midsection.
a substantially U shaped reservoir chamber having first and second U legs joined by a U midsection wherein the ratio of the height of the reservoir chamber to the height of the center of the U midsection is between about 1.7 and about 1.2;
a blood inlet at the base of said first U leg;
a blood outlet at the base of said second U leg;
a non-flexible filter element positioned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost portion of the U midsection.
6. The blood reservoir claimed in claim 5 wherein said filter element is more particularly defined as having the pore size between about 100 microns to about 250 microns.
7. The blood reservoir claimed in claim 5 wherein said substantially U shaped reservoir chamber is made from polyvinyl-chloride, polypropylene or polyurethane.
8. A flexible collapsible blood reservoir comprising:
a substantially U shaped reservoir chamber having first and second U legs joined by a U midsection, the cross-sectional area of said U being greatest at the U midsection and gradually decreasing toward each U leg base;
a filter element positioned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost portion of the U midsection.
a substantially U shaped reservoir chamber having first and second U legs joined by a U midsection, the cross-sectional area of said U being greatest at the U midsection and gradually decreasing toward each U leg base;
a filter element positioned at the U midsection and across the blood flow path between said blood inlet and said blood outlet; and a vent at the uppermost portion of the U midsection.
9. The blood reservoir claimed in claim 8 wherein said filter element is more particularly defined as having a pore size of between about 100 microns to about 250 microns.
10. The blood reservoir claimed in claim 8 wherein the ratio of the height of the reservoir chamber to the height of the center of the U midsection is between about 1.7 and about 1.2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US406,962 | 1982-08-10 | ||
US06/406,962 US4493705A (en) | 1982-08-10 | 1982-08-10 | Blood reservoir |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1195621A true CA1195621A (en) | 1985-10-22 |
Family
ID=23610065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000434169A Expired CA1195621A (en) | 1982-08-10 | 1983-08-09 | Blood reservoir |
Country Status (6)
Country | Link |
---|---|
US (1) | US4493705A (en) |
JP (1) | JPS5985666A (en) |
CA (1) | CA1195621A (en) |
DE (1) | DE3328562C2 (en) |
FR (1) | FR2550451A1 (en) |
GB (1) | GB2126484B (en) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59228849A (en) * | 1983-06-10 | 1984-12-22 | テルモ株式会社 | Apparatus for removing air bubbles in liquid |
WO1986001116A1 (en) * | 1984-08-09 | 1986-02-27 | Ruehland Dieter | Autotransfusion apparatus |
US4705505A (en) * | 1984-09-28 | 1987-11-10 | Fried Steven J | Rapid solution administration set with integral heat exchanger |
US4623333A (en) * | 1984-09-28 | 1986-11-18 | Fried Steven J | Fried-Grant rapid solution administration set with integral heat exchanger |
JPS61103451A (en) * | 1984-10-27 | 1986-05-21 | テルモ株式会社 | Blood storage tank |
US4643713A (en) * | 1984-11-05 | 1987-02-17 | Baxter Travenol Laboratories, Inc. | Venous reservoir |
US4734269A (en) * | 1985-06-11 | 1988-03-29 | American Hospital Supply Corporation | Venous reservoir bag with integral high-efficiency bubble removal system |
US4863452A (en) * | 1986-02-12 | 1989-09-05 | Minntech Corporation | Venous reservoir |
US4775360A (en) * | 1986-11-07 | 1988-10-04 | Lantech, Inc. | Autologus blood methods and apparatus |
US4772256A (en) * | 1986-11-07 | 1988-09-20 | Lantech, Inc. | Methods and apparatus for autotransfusion of blood |
JPS6411561A (en) * | 1987-07-07 | 1989-01-17 | Terumo Corp | Blood storage tank |
US4976682A (en) * | 1987-11-23 | 1990-12-11 | Lane Perry L | Methods and apparatus for autologous blood recovery |
JPH0622614B2 (en) * | 1988-06-21 | 1994-03-30 | テルモ株式会社 | Blood reservoir |
US5049146A (en) * | 1989-05-31 | 1991-09-17 | Baxter International, Inc. | Blood/gas separator and flow system |
US4964984A (en) * | 1989-06-14 | 1990-10-23 | Electromedics, Inc. | Blood filter |
US5061236A (en) * | 1990-07-16 | 1991-10-29 | Baxter International Inc. | Venous reservoir with improved inlet configuration and integral screen for bubble removal |
FR2673382B1 (en) * | 1991-03-01 | 1994-04-08 | Hospal Industrie | DEVICE FOR REMOVING GAS BUBBLES FROM A FLOWING LIQUID. |
US5269946A (en) * | 1991-05-22 | 1993-12-14 | Baxter Healthcare Corporation | Systems and methods for removing undesired matter from blood cells |
CH686027A5 (en) * | 1991-07-26 | 1995-12-15 | Elp Rochat | Unit of recovery and blood filtration. |
BE1005193A3 (en) * | 1991-08-21 | 1993-05-18 | Terumo Europ Nv | Device for the separation of blood constituents |
US5312352A (en) * | 1993-01-19 | 1994-05-17 | Datascope Investment Corp. | Bubble-free connector for liquid carrying tubing |
US5439448A (en) * | 1993-01-19 | 1995-08-08 | Datascope Investment Corp. | Bubble-free connector for liquid carrying tubing |
US6189704B1 (en) | 1993-07-12 | 2001-02-20 | Baxter International Inc. | Inline filter |
US5580349A (en) * | 1993-09-17 | 1996-12-03 | Avecor Cardiovascular, Inc. | Blood reservoir |
IT1260685B (en) * | 1993-09-29 | 1996-04-22 | Sorin Biomedica Spa | BLOOD CONTAINMENT DEVICE |
US5591251A (en) * | 1993-11-29 | 1997-01-07 | Cobe Laboratories, Inc. | Side flow bubble trap apparatus and method |
US5503801A (en) * | 1993-11-29 | 1996-04-02 | Cobe Laboratories, Inc. | Top flow bubble trap apparatus |
US20010037978A1 (en) | 1999-04-20 | 2001-11-08 | Daryl R. Calhoun | Filter assembly having a flexible housing and method of making same |
US6422397B1 (en) | 1993-12-22 | 2002-07-23 | Baxter International, Inc. | Blood collection systems including an integral, flexible filter |
US6367634B1 (en) | 1993-12-22 | 2002-04-09 | Baxter International Inc. | Blood collection systems including an integral, flexible filter |
US5772644A (en) * | 1993-12-28 | 1998-06-30 | Microtek Medical, Inc. | Filter pouch for stone and tissue sample collection |
US5643190A (en) * | 1995-01-17 | 1997-07-01 | Medisystems Technology Corporation | Flow-through treatment device |
US5769815A (en) * | 1995-05-25 | 1998-06-23 | Medisystems Technology Corporation | Blood chamber with integral projections |
US5772624A (en) | 1995-07-20 | 1998-06-30 | Medisystems Technology Corporation | Reusable blood lines |
CA2272307A1 (en) * | 1996-11-26 | 1998-06-04 | Medisystems Technology Corporation | Wide bubble traps |
US6117342A (en) * | 1996-11-26 | 2000-09-12 | Medisystems Technology Corporation | Bubble trap with directed horizontal flow and method of using |
US5983947A (en) | 1997-03-03 | 1999-11-16 | Medisystems Technology Corporation | Docking ports for medical fluid sets |
US6051134A (en) * | 1997-03-28 | 2000-04-18 | Medisystems Technology Corporation | Bubble trap having common inlet/outlet tube |
US6010623A (en) * | 1997-08-01 | 2000-01-04 | Medisystems Technology Corporation | Bubble trap with flat side |
US6337049B1 (en) * | 1998-08-28 | 2002-01-08 | Yehuda Tamari | Soft shell venous reservoir |
US6464666B1 (en) * | 1999-10-08 | 2002-10-15 | Augustine Medical, Inc. | Intravenous fluid warming cassette with stiffening member and integral handle |
US20030209479A1 (en) * | 2000-07-10 | 2003-11-13 | Lynn Daniel R | Blood filters, blood collection and processing systems, and methods therefore |
US6730267B2 (en) | 2001-02-09 | 2004-05-04 | Cardiovention, Inc. | Integrated blood handling system having active gas removal system and methods of use |
US6773670B2 (en) * | 2001-02-09 | 2004-08-10 | Cardiovention, Inc. C/O The Brenner Group, Inc. | Blood filter having a sensor for active gas removal and methods of use |
DE60336724D1 (en) | 2002-07-19 | 2011-05-26 | Baxter Healthcare Sa | SYSTEM FOR PERITONEAL DIALYSIS |
US7022099B2 (en) * | 2003-03-17 | 2006-04-04 | Cardiovention, Inc. | Extracorporeal blood handling system with automatic flow control and methods of use |
US7810674B2 (en) * | 2005-07-26 | 2010-10-12 | Millipore Corporation | Liquid dispensing system with enhanced mixing |
US7950547B2 (en) * | 2006-01-12 | 2011-05-31 | Millipore Corporation | Reservoir for liquid dispensing system with enhanced mixing |
US7927302B2 (en) * | 2007-04-24 | 2011-04-19 | Arizant Healthcare Inc. | High flow rate infusion unit and heat exchanger |
US7871462B2 (en) * | 2007-10-01 | 2011-01-18 | Baxter International Inc. | Dialysis systems having air separation chambers with internal structures to enhance air removal |
US8444587B2 (en) | 2007-10-01 | 2013-05-21 | Baxter International Inc. | Fluid and air handling in blood and dialysis circuits |
US7892332B2 (en) * | 2007-10-01 | 2011-02-22 | Baxter International Inc. | Dialysis systems having air traps with internal structures to enhance air removal |
US7892331B2 (en) * | 2007-10-01 | 2011-02-22 | Baxter International Inc. | Dialysis systems having air separation chambers with internal structures to enhance air removal |
US8123947B2 (en) * | 2007-10-22 | 2012-02-28 | Baxter International Inc. | Priming and air removal systems and methods for dialysis |
US8114276B2 (en) | 2007-10-24 | 2012-02-14 | Baxter International Inc. | Personal hemodialysis system |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US8425486B2 (en) * | 2008-11-21 | 2013-04-23 | Smisson-Cartledge Biomedical Llc | Collapsible fluid reservoir |
DK2229970T3 (en) * | 2009-03-16 | 2012-09-10 | Hoffmann La Roche | Bubble trap system for an infusion pump device |
WO2011002410A1 (en) * | 2009-07-03 | 2011-01-06 | Per Jonsson | Bubble reducer for eliminating gas bubbles from a flow |
US8382711B2 (en) | 2010-12-29 | 2013-02-26 | Baxter International Inc. | Intravenous pumping air management systems and methods |
DE102011084027A1 (en) | 2011-10-05 | 2013-04-11 | Maquet Cardiopulmonary Ag | Quick coupling device |
JP2013188441A (en) * | 2012-03-15 | 2013-09-26 | Asahi Kasei Medical Co Ltd | Air-bleeding device for extracorporeal circulation circuit and extracorporeal circulation circuit |
US9486590B2 (en) | 2014-09-29 | 2016-11-08 | Fenwal, Inc. | Automatic purging of air from a fluid processing system |
CA2985719C (en) | 2015-06-25 | 2024-03-26 | Gambro Lundia Ab | Medical device system and method having a distributed database |
US10625009B2 (en) | 2016-02-17 | 2020-04-21 | Baxter International Inc. | Airtrap, system and method for removing microbubbles from a fluid stream |
BR112018076977A2 (en) * | 2016-06-23 | 2019-04-16 | Medtronic, Inc. | venous air capture chamber |
WO2018114346A1 (en) | 2016-12-21 | 2018-06-28 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
US11357608B2 (en) * | 2019-02-16 | 2022-06-14 | Eyal Israely | Leech therapy device |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1923846A (en) * | 1929-03-16 | 1933-08-22 | Jose Grifols Y Roig | Blood transfusion apparatus |
US3527572A (en) * | 1965-10-11 | 1970-09-08 | A Edward Urkiewicz | Apparatus for treating blood |
US3554256A (en) * | 1968-11-08 | 1971-01-12 | Dave Champman Goldsmith & Yama | Flexible intravenous container |
US3827860A (en) * | 1972-06-15 | 1974-08-06 | Sherwood Medical Ind Inc | Blood oxygenation device |
JPS544121Y2 (en) * | 1974-07-05 | 1979-02-23 | ||
US4164468A (en) * | 1975-01-20 | 1979-08-14 | Bentley Laboratories, Inc. | Blood treating device and method of operation |
US4026669A (en) * | 1975-07-14 | 1977-05-31 | Baxter Laboratories, Inc. | Variable capacity reservoir assembly |
US4047326A (en) * | 1975-12-05 | 1977-09-13 | Tibbs Robert C | Vascular contact rotating and stationary abrading electrode devices for electric weed killing |
AU3775578A (en) * | 1977-07-08 | 1980-01-10 | Johnson & Johnson | Vented filter assembly |
DE2818390C2 (en) * | 1978-04-27 | 1986-10-30 | Fresenius AG, 6380 Bad Homburg | Artificial organ |
US4368118A (en) * | 1980-01-07 | 1983-01-11 | Siposs George G | Blood-air separator and filter |
US4344777A (en) * | 1980-01-07 | 1982-08-17 | Siposs George G | Directed flow bubble trap for arterial blood |
SE448518B (en) * | 1981-02-16 | 1987-03-02 | Gambro Dialysatoren | FLOW ROOM FOR BLOOD OR SIMILAR VENTURES |
-
1982
- 1982-08-10 US US06/406,962 patent/US4493705A/en not_active Expired - Fee Related
-
1983
- 1983-08-04 GB GB08321045A patent/GB2126484B/en not_active Expired
- 1983-08-08 DE DE3328562A patent/DE3328562C2/en not_active Expired
- 1983-08-09 CA CA000434169A patent/CA1195621A/en not_active Expired
- 1983-08-09 JP JP58145626A patent/JPS5985666A/en active Pending
- 1983-08-09 FR FR8313093A patent/FR2550451A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2550451A1 (en) | 1985-02-15 |
DE3328562A1 (en) | 1984-02-16 |
GB2126484B (en) | 1986-04-16 |
GB2126484A (en) | 1984-03-28 |
JPS5985666A (en) | 1984-05-17 |
US4493705A (en) | 1985-01-15 |
DE3328562C2 (en) | 1986-06-19 |
GB8321045D0 (en) | 1983-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1195621A (en) | Blood reservoir | |
US6017493A (en) | Vacuum-assisted venous drainage reservoir for CPB systems | |
US6337049B1 (en) | Soft shell venous reservoir | |
US5318510A (en) | Collection device | |
DK170294B1 (en) | Device for circulating blood outside the body through cardiovascular assistance | |
CA1086594A (en) | Mass transfer between fluids and apparatus therefor | |
WO2002047609A3 (en) | Feedback control of ultrafiltration to prevent hypotension using osmotic pressure | |
CA2299506C (en) | System and method for minimally invasive surgery with vacuum-assisted venous drainage | |
US20030175149A1 (en) | Renewable, modifiable, membrane gas exchanger | |
US2854002A (en) | Oxygenator | |
AU6041190A (en) | Combined hemofiltration and hemodialysis system | |
Faulkner et al. | Trouble shooting the extracorporeal membrane oxygenator circuit and patient | |
CN1051303A (en) | Wearing type filtering device for blood dialysis | |
Ündar et al. | Design of a physiologic pulsatile flow cardiopulmonary bypass system for neonates and infants | |
Naruse et al. | Development of a new extracorporeal whole-liver perfusion system | |
WO2003097130A1 (en) | Device and system for filtering blood | |
Grubitzsch et al. | Pumpless arteriovenous extracorporeal lung assist: what is its role? | |
Tamari et al. | A new bladder allows kinetic venous augmentation with a roller pump | |
De Somer et al. | D-901 neonatal oxygenator: a new perspective | |
Sueda et al. | Development of an intravascular pumping oxygenator using a new silicone membrane | |
Bramson et al. | The membrane lung | |
KR900006848B1 (en) | Extracoporeal blood exygenatoror which has blood reservoir | |
Ehren et al. | In-vitro evaluation of neonatal ECMO cannulae with regard to flow characteristics | |
JPS6220218Y2 (en) | ||
Page | Clinical evaluation of a new microporous Teflon membrane oxygenator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEC | Expiry (correction) | ||
MKEX | Expiry |